Skip to main content
OpenTrials
Completed

NCT Number: NCT05073406

Cognition at Altitude in HEMS - Part II

The aim of the current study is to evaluate under blinded conditions, both in a simulated environment and during helicopter flight, the effect of a rapid (within 20 minutes) exposure to altitude (4000 m asl) on physiological parameters and selected cognitive domains, in providers operating in helicopter emergency medical service (HEMS) exposed to hypobaric hypoxia or to hypobaric normoxia (H0: cognitive effects under hypobaric hypoxia = cognitive effects under hypobaric normoxia). Simulated environment will allow to control different factors. The parallelism between a study branch conducted in a simulated environment and another one conducted under a real-life condition will allow to evaluate the additive effects on additional stressor factors (processive and systemic ones).

* Simulation branch: each participant will take part in three research sessions: a familiarization session and two experimental sessions in simulation facility called terraXcube (test 1 and 2). On test 1 and test 2 each group will be exposed twice to the simulated altitude of 4000 m asl (under hypobaric hypoxia or hypobaric normoxia conditions) according to the randomization protocol. Participants will perform the neurocognitive tests three times on each of the two tests: before the ascent (TC0), after 5 min from the end of the ascent (TC1) and after around 30 min (TC2), to investigate European Union Aviation Safe Agency (EASA) proposed recommendations. After completing each neurocognitive test session, participants will be asked to rate their performance using a visual analogue scales (VAS). All participants will wear the vital parameters monitoring system during the entire duration of the tests inside the chamber, as well as the cerebral oxygen saturation (ScO2) sensor. Samples will be collected by saliva, urine and/or capillary blood. The same schedule is repeated in each test session. * In-field branch: each participant will take part in three research sessions: a familiarization session and two experimental sessions during helicopter flights (test 1 and 2). On test 1 and test 2 each group will be exposed twice to the altitude of 4000 m (under hypobaric hypoxia or hypobaric normoxia conditions) according to the randomization protocol. Participants will perform the neurocognitive test two times on each test: before the ascent (TC0), after around 5 min from the end of the ascent (TC1). After completing each neurocognitive tests, participants will be asked to rate their performance using a visual analogue scales (VAS). All participants will wear the vital parameters monitoring system during the entire duration of the tests. Samples will be collected. The same schedule is planned in each test session.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Eurac Research, Institute of Mountain Emergency Medicine

Bolzano, BZ, 39100, Italy

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • members of emergency medical services (EMS) and search and rescue (SAR) services with an occupational licence;
  • an age between 18 and 60 years;
  • an American Society of Anaesthesiologists (ASA) physical status class I;
  • provided informed and written consent;
  • no current COVID 19 symptoms and temperature ≤ 37.5°on test days, not being tested positive for COVID-19, ideally COVID-19 vaccinated.

Exclusion criteria

  • members under the age of 18 years;
  • an ASA physical status class II or more;
  • a medical history of psychiatric disorders and neurological diseases;
  • previous high altitude pulmonary oedema (HAPE) or high altitude cerebral oedema (HACE) or severe acute mountain sickness (AMS) (defined as a Lake Louise Score (LLS) > 9) occurred at altitudes similar to the ones tested in the study;
  • no informed consent;
  • current COVID 19 symptoms, being tested positive for COVID-19 or symptoms and body temperature ≥ 37.5°on test days.

Treatment and study plan

Altitude exposure in hypobaric normoxic condition

Other

Altitude exposure with oxygen supplementation to achieve normoxia at altitude

Altitude exposure in hypobaric hypoxic condition

Other

Altitude exposure with air supplementation to obtain a sham comparator arm

Primary outcomes

  1. Psychomotor Vigilance Test - PVT

    Time frame: Changes from baseline (T0) to altitude measurement (respectively after 5 min - T1 and after 30 min - T2)

    Changes in reaction time using a computer-based test (PVT)

  2. Digit-Symbol Substitution Task - DSST

    Time frame: Changes from baseline (TC0) to altitude measurement (respectively after 5 min - TC1 and after 30 min - TC2)

    Changing in processing speed using a computer based test (DSST)

  3. 2-back Test

    Time frame: Changes from baseline (TC0) to altitude measurement (respectively after 5 min - TC1 and after 30 min - TC2)

    Changing in working memory using a computer based test (2-back test)

Sponsors and collaborators

Lead sponsor

Institute of Mountain Emergency Medicine

Other

Collaborators

  • Medical University Innsbruck
  • University Grenoble Alps
  • Università degli Studi di Trento

Registry information

Official study title

Cognitive Performance After Acute Exposure to Altitude - Part II

Acronym: HEMS II

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Oct 11, 2021
Registry last updated
Mar 1, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.